A Study of Different Titration Schedules of ALKS 5461 in Adults With Major Depressive Disorder (MDD)

Status:
Completed

Trial end date:
2014-09-01

Target enrollment:

Participant gender:

This is a Phase 3 study designed to evaluate the safety and tolerability of two titration schedules for ALKS 5461.

Phase 3

Alkermes, Inc.